Podcasts about nemours children's health

This episode features Dr. R. Lawrence Moss, President and CEO of Nemours Children's Health. Here, he discusses his journey and insights into pediatric healthcare. He also sheds light on his concerns about the healthcare system's narrow focus on volume over outcomes and shares his thoughts on the progress and challenges in pediatric healthcare today.

Teenagers who are Black and of lower socioeconomic status have major complications after surgery for the most common type of scoliosis.That's according to a new study published by Nemours Children's Health, which also found the same black and low-income teenage patients are more likely to return to the Emergency Department within 90 days of surgery.Delaware Public Media's Joe Irizarry is joined this week by Dr. Suken Shah – the study's senior author and pediatric orthopedic surgeon at Nemours Children's Health – to learn more about the disparities in scoliosis surgery.

Dr. Kara Odom Walker, Executive Vice President, Chief Population Health Officer, Nemours Children's Health, discussed the health system's commitment to community health, the social determinants of health as well as food insecurity in the region.  She spoke on the surprising three areas most Delawareans reported as impacting their health and security most – stable housing, food and internet access.  Not only do these issues affect health, they impact education, employment and mental health.  She discussed their unique National Office, their voice in DC, the only children's hospital to maintain an office to inform and lobby on behalf of health. Nemours is working to establish youth behavioral health care in emergency rooms, offer primary preventative care, create school-based Wellness Centers that address social services and health, and support the SNAP program for continuing food access for families.  For more information go to Nemours.org

This episode features Dr. Lawrence Moss, President and CEO of Nemours Children's Health. Here, he discusses his new e-book Finding Health by Looking in the Right Place: How Understanding What Actually Creates Health Can Fix U.S. Healthcare.

This episode features Dr. Lawrence Moss, President and CEO of Nemours Children's Health. Here, he discusses his new e-book Finding Health by Looking in the Right Place: How Understanding What Actually Creates Health Can Fix U.S. Healthcare.

Description: Co-host Mary Jo Strobel, APFED's Executive Director, is joined by co-host Holly Knotowicz, a speech-language pathologist and feeding specialist living with eosinophilic esophagitis (EoE) who serves on APFED's Health Sciences Advisory Council. They talk with guest Dr. James Franciosi, Chief of the Division of Gastroenterology, Hepatology, and Nutrition at Nemours Children's Health in Orlando, Florida. In this episode, Mary Jo Strobel and Holly Knotowicz interview Dr. James Franciosi about his research with proton pump inhibitors, personalized medicine, the different factors that influence the response EoE patients may have to very high dose PPI treatments and other treatments, including dietary eliminations, swallowed oral steroid medications, and for some patients, biologic medications. Dr. Franciosi explains the uses of these various treatments and compares the risks of medical treatments with the risk of untreated EoE. He also describes the potential for advances in treatment choices.   Disclaimer: The information provided in this podcast is designed to support, not replace the relationship that exists between listeners and their healthcare providers. Opinions, information, and recommendations shared in this podcast are not a substitute for medical advice. Decisions related to medical care should be made with your healthcare provider. Opinions and views of guests and co-hosts are their own.   Key Takeaways: [:49] Co-host Mary Jo Strobel welcomes co-host Holly Knotowicz. Holly introduces the topic of proton pump inhibitors and EoE.   [1:28] Holly introduces Dr. James Franciosi, Chief of the Division of Gastroenterology, Hepatology, and Nutrition at Nemours Children's Health in Orlando, Florida.   [1:39] Since 2008, Dr. Franciosi has cared for children and teens with eosinophilic esophagitis (EoE) and eosinophilic gastrointestinal diseases (EGIDs). His team's mission is to reduce the symptoms of EoE and EGIDs and they have published more than 60 peer-reviewed publications.   [1:55] Holly thanks Dr. Franciosi for joining the podcast.   [2:06] Dr. Franciosi “grew up” with Beth Mays (now Beth Allen), whose family suffered from eosinophilic GI disease. When Dr. Franciosi was at the Children's Hospital of Philadelphia (CHOP), he became very interested in eosinophilic esophagitis, which was starting to emerge as something that was different from gastroesophageal reflux.   [2:30] Dr. Franciosi had the opportunity to work with Dr. Liacouras, Dr. Spergel, and many others at CHOP. He transitioned to Cincinnati Children's Hospital with the leadership of Dr. Marc Rothenberg, Dr. Phil Putnam, and a group trying to optimize the care for children with eosinophilic GI disease.   [3:01] Dr. Franciosi then moved to a leadership role at Nemours Children's Health in Orlando, Florida. He has been with Nemours Children's Health for the past 11 years. There he has done additional research in eosinophilic disease and seen many changes for the good with these conditions.   [3:37] Mary Jo notes that early in his career, Dr. Franciosi had worked with Beth Mays, now Beth Allen, who is one of the founders of APFED. Dr. Franciosi has been working with eosinophilic diseases since the time APFED was founded.   [3:56] Dr. Franciosi has conducted research into how the role of proton pump inhibitors (PPIs) in the evaluation and treatment of EoE has evolved over time. His team is very interested in what therapies may be effective for eosinophilic esophagitis (EoE) for individual patients.   [4:24] The research Dr. Franciosi has been doing for EoE and other conditions is trying to look at the right drug for the right patient, with the right dosing, etc. He calls that precision medicine or personalized medicine.   [4:39] Proton pump inhibitors (PPIs) are medications that have been around for decades. There has been an evolution of thought about whether this is a medicine that we use to define the condition of EoE or now something we can use as a treatment option.   [4:57] There have not been any randomized, placebo-controlled clinical trials for EoE using this medication and there has been a lot of variability in the literature about how well they work. That's some of the research Dr. Franciosi has been looking into and also making sure that these are communicated as an option for the right patients with EoE.   [5:27] PPIs are traditionally thought of as blocking one of the common pathways for acid in the stomach. A proton pump in parietal cells in the GI tract pumps acid into the stomach that helps you fight bad bacteria. Sometimes the acid can cause irritation in the GI tract,  the stomach, and the esophagus. The PPIs work to block those pumps.   [6:15] Over the past several decades, the thinking around EoE has evolved from it being thought to be a reflux condition that had a lot of eosinophils or allergic cells, that just didn't get better, to being thought of as strictly different from reflux, to thinking that it may be a mix for some patients.   [6:42] As the first guidelines for EoE were developed, the initial thought was to use the PPI medications to exclude gastroesophageal reflux. In the first consensus guidelines, patients had to fail the proton pump inhibitors at a high dose to be defined as EoE. This has changed over time. In 2018 there were new guidelines with new research.   [7:15] The newer thinking is that the PPIs are not to make the diagnosis, but they're one of several different therapies that we can use; dietary interventions and different medications, including PPIs, swallowed steroids, and some of the newer biologic medications.   [8:14] H2 blockers are some of the older medications that block acid in the stomach, but they block it in a different way. They block the histamine type-2 receptor, one of the pathways by which acid is produced in the stomach. The proton pump inhibitors block the proton pump. They're stronger medications and they work better for acid.   [8:46] The H2RA medications have names that end in “tidine” like famotidine. The PPI medications have names that end with “azole” like pantoprazole or esomeprazole.   [9:45] EoE is a condition that we've learned a lot about over the past several decades. The PPI medications may have different functions. They may block the acid in the stomach; they may also have a role in reducing some of the inflammation. This led to questioning if PPIs should be used to make a diagnosis or as a choice of therapy.   [10:36] From the 1990s to the 2000 era, to the most recent guidelines in 2018, the thinking about the treatment of EoE and the use of PPIs has evolved.   [10:49] One of the important things to know is that just because you've been on a PPI, doesn't mean that you're on a high dose of PPI therapy. This is important in children and different practices.   [11:12] The general recommendation for PPI therapies is to use a high dose of PPI twice a day. For adults, that's 40 mg of esomeprazole twice a day. For children, it's 1 mg per kg of body weight twice a day. That's a high dose. For some people, it may be that the medication was not used at a high dose.   [11:37] The goal ultimately is to back off the high dose and to decrease the amount of medication that's being administered.   [11:47] Dr. Franciosi says the main surprise in his findings was that the studies in both adults and children are “all over the place.” Some people report a 30% or 20% response; other colleagues throughout the world have reported a response of about two-thirds of the patients. It was surprising to see how variable the response was.   [12:18] Dr. Franciosi thinks there is variation in the choice of PPI medications, the dosing, and how they're administered. Dr. Franciosi and his team are also looking at how people respond to these medications. That's where personalized medicine comes in; your genes, and factors in your body can influence how well you are responding.   [12:53] Precision medicine has been used in pediatric gastroenterology for inflammatory bowel disease with medications like 6-mercaptopurine, azathioprine, and some of the biologic medications. People can respond differently to medication. Genetic variation or other factors may create different patterns of response to the same medications.   [13:25] Precision medicine and personalized medicine are interchangeable terms.   [13:48] Before reviewing the literature for his most recent publication, Dr. Franciosi had done some genetic testing and identified that there are genetic variations that do influence how people respond or don't respond to the PPI medications.   [14:09] We need to learn more about genetic variations. Dr. Franciosi thinks for every new diagnosis of EoE, PPIs should be considered as a medication. It's important for patients and families to know the different options. Providers may have their own biases but they should lay out the options for their patients and families to decide.    [14:47] Dietary intervention has significant benefits for children, teens, and adults. There can be hardships with quality of life that have to be considered. Taking medication for the long term also has considerations. The newer biologic medications are a fantastic step forward but they are expensive. They are just starting to be used for EoE.   [15:21] Dr. Franciosi likes to identify to his patients that there are options in treatments: dietary elimination, proton pump inhibitors, swallowed steroids, and biologic medication for people who have strictures (narrowing) in their esophagus or fibro stenosis (scar tissue). These patients are less likely to respond to PPI medication.   [15:57] We need to do more research on this and more future prospective trials, patients with scarring are those where a different type of therapy beyond the PPI medications. Patients with inflammatory symptoms seem to respond to PPI medication.   [17:04] Dr. Franciosi's patients and families are making some choices together. Dietary elimination may not be the right choice for certain patients but they need to have the option. Dr. Franciosi presents dietary elimination as effective for many patients. It's an investment upfront. It presents the benefit of not using long-term medications.   [17:44] Sometimes when children have growth concerns, or the dietary interventions don't work or are not possible, different medications may be considered.   [18:13] The benefit of using PPIs in treatment is that you can reduce the inflammation that's occurring, alleviate symptoms and make patients feel better. There has been some debate about whether this is related to the acid primarily in the stomach and some breaks in the esophagus lining that cause antigens to go in and cause inflammation.   [18:51] Dr. Franciosi uses a balanced approach with patients and families. He tells them every treatment has risks associated with it. Also, not treating EoE has risks. He did studies at Cincinnati on what happened to patients 15 years later if they were untreated. It can involve more scar tissue, strictures, symptoms, and growth issues.   [19:37] PPIs have gotten a lot of bad press over the past few years, primarily looking at the rates of infection. When you block stomach acid, that acid is no longer there to kill bad bacteria. So there are more associated respiratory infections and stomach infections like gastroenteritis, GI bugs, etc.   [20:02] Other risks that have been talked about are dementia and kidney issues, often in older populations and patients who are generally sicker. Many people are on PPIs for general GI disorders unnecessarily. If you don't need a drug, you shouldn't be on it.   [20:34] The risk/benefit analysis of the infections, and other people have talked about low bone mineral density, etc., have to be balanced with the risk of untreated disease and the potential risk of other medications, as well.   [21:14] For the vast majority of patients, EoE is a chronic, long-term condition. Once you take the treatment away, whether that's eliminating foods, or taking medication, the condition will come right back. That's also true with proton pump inhibitors.   [21:36] The recommended approach for PPIs is a high dose of medication twice a day, to start, a repeat endoscopy after eight to 12 weeks, and come down to maintenance, which would just be once a day.   [21:55] Colleagues in Spain, who have published on this, have said about two-thirds of patients responded to the really high dose PPI medications and that among those people that respond, about two-thirds continue on maintenance and do well. Not everybody will necessarily respond or do OK with the lower dose of medication.   [22:17] In general, if you take away the medications or the treatment that you're using, the disease will come right back and those risks of progression or scar tissue, creating strictures, and developing symptoms would return as well.    [22:39] If you are considering PPIs, ask your doctor their perspective on the different treatments that Dr. Franciosi has been discussing here. Considerations include PPIs, dietary elimination, swallowed steroid medications, and for some patients, biologic medications. Dr. Franciosi thinks biologics will become more used over the years.   [23:43] Dr. Franciosi would recommend asking a treating provider about the choice of PPI medications, the dosing that they're planning to use, whether or not it is high-dose medication, and even what the plan is for coming down off the medication with an endoscopy or a transnasal endoscopy in eight to 12 weeks, and maintenance.   [24:03] In the U.S., high-dose PPI may not be covered by insurance. They may approve 40 mg of esomeprazole once a day but not twice a day, or make it challenging to get approved. The patients may do the second dose over the counter and Dr. Franciosi will walk them through how to do that.   [24:58] Dr. Franciosi thinks the ideal would be that patients are diagnosed with eosinophilic esophagitis and then get a cheek swab to determine their profile and what kind of response they will have using esomeprazole or if he recommends oral viscous budesonide or fluticasone. It would also be great to identify who may respond or not respond to biologic medications.   [25:37] The ideal of personalized or precision medicine is to be able to identify the right choice of treatment, including dietary approaches, for the right patient, at the right dosing.   [25:50] An underappreciated area for EoE is recognizing that we don't have good testing to identify food reactions, allergies, etc. It would be wonderful. Allergy testing doesn't correlate because it's mostly IgE based. So that's a reason for dietary elimination.   [26:38] Mary Jo and Holly thank Dr. Franciosi for participating in the podcast. Dr. Franciosi says the takeaway is that PPIs should be considered as an option for various patients.   [27:20] To learn more about eosinophilic esophagitis, visit apfed.org/eoe, apfed.org/specialists, and apfed.org/eos-connections. Holly and Mary Jo thank APFED's education partners, linked below.   Mentioned in This Episode: American Partnership for Eosinophilic Disorders (APFED) APFED on YouTube, Twitter, Facebook, Pinterest, Instagram Nemours Children's Health Children's Hospital of Philadelphia Cincinnati Children's Hospital Beth Allen Real Talk: Eosinophilic Diseases Podcast   Education Partners: This episode of APFED's podcast is brought to you thanks to the support of AstraZeneca, Bristol Myers Squibb, Sanofi, and Regeneron.   Tweetables:   “We've been very interested in what therapies may be effective for eosinophilic esophagitis, or EoE. The research that we've been doing … is trying to look at the right drug for the right patient, at the right dosing, etc.” — James Franciosi, MD    “The main benefit [of using PPIs as a treatment for EoE] is that you can reduce the inflammation that's occurring, [and] alleviate symptoms to make patients feel better.” — James Franciosi, MD   “Once you take the treatment away, whether that's eliminating foods, or taking medication, for the vast majority of people, the condition will come right back. That's also true with proton pump inhibitors.” — James Franciosi, MD   Featured speaker: Dr. James Franciosi Gastroenterology at Nemours Children's Health, Florida  

In this sixth episode of Morning Sign In, Morning Sign Out (MSO) Outreach Director Jenny Lee, writer Audrey Banzali-Marks, and editor Hope Harris talk about the latest research on the relationship between eczema and dietary fiber, as well as how the modern Western Diet could affect our health based on the researchers' results.  Audio editing: Jenny Lee, Outreach Director Speakers: Jenny Lee, Outreach Director; Audrey Banzali-Marks, Writer; Hope Harris, Editor MSO Website:  https://www.msoatucla.org/ Audrey Banzali-Marks' Article: https://www.msoatucla.org/feeding-the-fight-against-eczema-how-fiber-strengthens-skin.html Trompette et al.'s Research: https://www.sciencedirect.com/science/article/pii/S1933021922000113?via%3Dihub Other sources used in this episode: National Eczema Association Website: https://nationaleczema.org/eczema/ National Eczema Association's eczema statistics: https://nationaleczema.org/research/eczema-facts/ Medline Plus' carbohydrate information: https://medlineplus.gov/carbohydrates.html The Harvard School of Public Health's information on dietary fiber recommendations: https://www.hsph.harvard.edu/nutritionsource/carbohydrates/fiber/ Mayo Clinic's information on symptoms of insufficient dietary fiber in the diet: https://www.mayoclinic.org/healthy-lifestyle/nutrition-and-healthy-eating/in-depth/fiber/art-20043983#:~:text=Dietary%20fiber%20increases%20the%20weight,Helps%20maintain%20bowel%20health. Nemours Children's Health information on keratinocytes: https://kidshealth.org/en/parents/skin-hair-nails.html#:~:text=Keratinocytes%20(ker%2Duh%2DTIH,protect%20the%20body%20against%20infection. Rakhra et al.'s information on the Western Diet: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721435/ Bylund et al.'s information on the prevalence and incidence of atopic dermatitis: https://medicaljournalssweden.se/actadv/article/view/1691 National Eczema Association's information on eczema diets: https://nationaleczema.org/diet-nutrition/

In value-based care, we have both an economic and a moral imperative.  What's at stake is so much more than saving our healthcare system. It is about ensuring the continued prosperity of our nation to ensure that we leave it better for future generations. The best indicator of whether our country is on the right path is the assurance that healthy mothers can give birth to healthy children. And those children, in turn, must be assured of good care and a sound education that will enable them to face the challenges of a changing world. If we could have but one generation of properly born, educated, and healthy children, many of the insurmountable problems in our country would vanish in our lifetimes. This week on the Race to Value, you are going to hear from a value-based care leader who is boldly moving beyond with a call to action to serve our nation's youth. Karen Wilding, the Chief Value Officer at Nemours, is on a passionate pursuit of the Quadruple Aim, and her health system is redefining children's health in our country. Nemours Children's Health is truly “leaning in” to the promise of population health by transforming the very definition of what it means for children to be healthy. And their value journey reflects a bold vision to create the healthiest generations of children that will take us beyond medicine by ultimately impacting the world. If you are looking for an example of inspirational leadership in value-based care, look no further than Karen Wilding and the Nemours Children's Health System!   Episode Bookmarks: 01:30 “If we could have but one generation of properly born, educated, and healthy children, many of the insurmountable problems in our country would vanish in our lifetimes.” 02:30 Introduction to Karen Wilding, the Chief Value Officer at Nemours Children's Health 03:00 Support Race to  Value by subscribing to our weekly newsletter and leaving a review/rating on Apple Podcasts. 05:45 Karen describes the whole-person care orientation at Nemours and how the mission of “Well Beyond Medicine” guides their value-based care journey. 06:45 Social Determinants of Health (SDOH) screening in underserved populations to expand care network and create community partnerships. 07:45 Driving “macro-system impact” as an anchor institution (e.g. best practice clinical research, cross-sector partnerships, health equity investments) 08:30 Health Equity opportunities in pediatric whole-person care (e.g. teen birth rates, preventative care access, infant mortality rates…and even household income). 09:00 “Well Beyond Medicine is a commitment to not just care for the medical aspects of children – we also care for the larger health ecosystem to create whole-child health and healthier generations.” 11:45 “Payment transformation is foundational to being able to create sustainability in value-based care.” 12:30 Karen explains how the fee-for-service infrastructure does not align incentives for healthy outcomes (e.g. asthma exacerbations with children in Delaware). 13:30 “Investing in children's health is the single most important thing we can do as a society.” (balancing present-day economics vs. future economics). 14:45 Partnering with payers to pursue health equity transformation and the importance of community-based investments. 16:45 Nemours has been utilizing Community Health Workers to conduct SDOH screenings and individualized interventions through a culturally competent care model. 17:45 Karen explains how the interdisciplinary care team at Nemours works together to capture, assess, and address SDOH barriers. 18:45 The importance of enterprise-level buy-in when launching a SDOH population health strategy. 20:30 Overcoming fears and concerns of families in sharing personal information about their social barriers. 21:00 The creation of a national toolkit on whole-child population health and how Nemours is collaborating with policy stakeholders at the federal level.

Ensuring the U.S. has a well-trained pediatric workforce is critical. Listen in as Dr. Larry Moss, President and CEO, Nemours Children's Health, and Amy Knight, President of the Children's Hospital Association, discuss Children's Hospitals Graduate Medical Education funding. They offer policy recommendations to address the current pediatric workforce shortage, including a call to Congress to increase CHGME funding, reauthorization of the program, and more. Carol Vassar, producer

On Mar. 2, 2023, the Lisa Dean Moseley Foundation of Wilmington, Delaware donated $78 million to dramatically expand Nemours' capacity to provide clinical care for children with cancer, sickle cell disease, and other blood disorders. Learn more about this donation, including how it happened, from William (Bill) Martin, President of the Lisa Dean Moseley Foundation, and Mark Mumford, Chief Operating Officer for Nemours Children's Health.  Carol Vassar, producer

On this episode of DGTL Voices, Ed is joined by Karen Wilding, Chief Value Officer at Nemours Children's Health, one of the nation's leading pediatric health systems to chat care across the continuum.   

In this special sponsored episode, we're discussing how ambient clinical intelligence can improve patient care and reduce clinician burnout. Our sponsor is the Dragon Ambient Experience, or DAX, an ambient clinical intelligence solution from Nuance Communications and Microsoft. I'm joined by Alfred Atanda Jr., MD, a pediatric orthopedic surgeon at Nemours Children's Health in Delaware. He is chief of the Center for Sports Medicine and the Chief of Clinician Experience, as well as an assistant professor of orthopedic surgery at the Sidney Kimmel Medical College at Thomas Jefferson University. We discuss the challenges of declining physician well-being and the potential solutions to address it. We'll also be discussing the impact of clinical documentation on burnout and how ambient clinical intelligence solutions like DAX can help alleviate these burdens. Join us as we discuss Dr. Atanda's experiences with burnout and clinical documentation and the benefits of using ambient clinical intelligence in their practice. Find out more at https://nuance.com/exploreDAX The Podcast by KevinMD is brought to you by the Nuance Dragon Ambient eXperience. With so many demands on their time, physicians today report record levels of burnout. Burnout is caused by many factors, one of which is clinical documentation. Studies indicate physicians spend two hours documenting care for every hour spent with patients. At Nuance, we are committed to helping physicians do what you love – care for patients – and spend less time on clinical documentation. The Nuance Dragon Ambient eXperience, or DAX for short, is an AI-powered, ambient clinical intelligence solution that automatically captures patient encounters securely and accurately at the point of care. Physicians who use DAX have reported a 50 percent decrease in documentation time and a 70 percent reduction in feelings of burnout, and 83 percent of patients say their physician is more personable and conversational. Rediscover the joy of medicine with clinical documentation that writes itself, all within the EHR. VISIT SPONSOR → https://nuance.com/exploreDAX SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RATE AND REVIEW → https://www.kevinmd.com/rate FOLLOW ON INSTAGRAM → https://www.instagram.com/kevinphomd FOLLOW ON TIKTOK → https://www.tiktok.com/@kevinphomd

This episode features conversations about raising resilient kids based on the video series of the same name. It's a partnership between Nemours Children's Health and the Michael Phelps Foundation and features the most decorated Olympian of all time and his wife, Nicole, as your hosts. Together, they talk with Nemours experts about the world's hardest job: being a parent. Nicole and Michael are the parents of three young sons and face the same concerns and challenges that all parents do when it comes to helping kids grow to be healthy, happy, and resilient.  Learn more about the Michael Phelps Foundation Carol Vassar, producer

In this episode, we are joined by Cami Mitelman, Customer Success Manager at NRC Health, and Dr. Peggy Greco, Chief Patient Experience Officer at Nemours Children's Health, to discuss what diversity, equity and inclusion looks like in patient experience, how NRC provides Nemours the capability to identify disparities in the patience experience and more. This episode is sponsored by NRC Health.

This episode explains the care and process available when serious pediatric trauma occurs. Dr. John Draus is the Chief of Pediatric Surgery at Nemours Children's Health and he also serves as the Trauma Medical Director for the Trauma Program at Wolfson Children's Hospital. Dr. Draus came to Wolfson in July of 2022 after having served as the Trauma Medical Director at the University of Kentucky's level 1 pediatric trauma center from 2015-2021 and chief medical officer from 2021-2022. Lisa Nichols is the Trauma Program Manager at Wolfson Children's Hospital. Lisa came to Wolfson in November of 2019 to manage the program at Wolfson. She has over 15 years of pediatric trauma program management experience and over 34 years of pediatric nursing expertise. Lisa is the current president of the Pediatric Trauma Society and also works as a pediatric nurse reviewer with the American College of Surgeons verifying other trauma centers are meeting ACS standards. Lisa Nichols MBA, BSN, RN, CCRN-K | Pediatric Trauma Program Manager | Wolfson Children's Hospital | Lisa.Nichols@bmcjax.com |  Office 904-202-8397 | Fax 904-202-8431 | Cell 402-305-6657Helpful linkshttps://www.wolfsonchildrens.com/about/car-safetyhttps://www.wolfsonchildrens.com/about/safe-kids-northeast-floridahttps://www.myflfamilies.com/service-programs/child-welfare/caregivers/child-passenger-safety.shtml 

CPTS is part of the National Child Traumatic Stress Network (NCTSN). It brings together a unique multi-disciplinary team headquartered at three institutions: Children's Hospital of Philadelphia, Nemours Children's Health, and University of Kentucky HealthCare. We work closely with familyadvocates and frontline healthcare providers around the United States and internationally. Our mission is to reduce pediatric medical traumatic stress by promoting trauma-informed healthcare. We reach healthcare providers and systems - disseminating evidence-based practices and screening tools and training providers to recognize and address traumatic stress in children. We provide resources for pediatric patients and their families in English and Spanish.

Spine enthusiasts, rejoice!  An expert panel joins the podcast to discuss and debate the techniques, indications, and all aspects of performing Posterior Column Osteotomies for pediatric spine deformity. Your hosts are Lorena Floccari from Akron Children's Hospital, Kenneth Illingworth from Cedars-Sinai Hospital LA, and Craig Louer from Vanderbilt Children's Hospital. Music by A. A. Alto. Expert Panel: Haemish Crawford, FRACS.  Starship Children's Hospital; Auckland, New Zealand James O. Sanders, MD.   University of North Carolina; Chapel Hill, NC Suken A. Shah, MD.  Nemours Children's Health; Wilmington, DE Daniel J. Sucato, MD, MS.   Scottish Rite Hospital; Dallas, TX   This installment is performed in conjunction with the Journal of the Pediatric Orthopedic Society of North America (JPOSNA). The Feb 1, 2023 release of JPOSNA includes a critical concepts review article on PCO technique and use in addition to a transcript form of this panel discussion.  February 2022 JPOSNA Table of Contents: https://jposna.org/index.php/jposna PCOs in AIS Current Concepts Review: https://jposna.org/index.php/jposna/article/view/638 PCO Expert Panel: https://jposna.org/index.php/jposna/article/view/639    

INTERVIEWS IN THIS EDITION 1. Amy Bailes, PT PhD Director of Physical Therapy Research, Cincinnati Children's Hospital Medical Center, Cincinnati, OH “Inpatient Physical Therapy After Orthopedic Lower Extremity Surgery in Children With Cerebral Palsy” A new study in Pediatric Physical Therapy reveals the proportion of children with cerebral palsy having physical therapy during inpatient stay after their orthopedic lower extremity surgery. The value of such therapy to inpatient care is discussed by lead author Amy Bailes. 2. Rachel Bican, PT, DPT, PhD Assistant Professor, Division of Physical Therapy, Ohio University, Athens, Ohio “Comparison of Gross Motor Outcomes Between Children With Cerebral Palsy From Appalachian and Non-Appalachian Counties” Pediatric Physical Therapy researcher Rachel Bican talks about her investigation of cerebral palsy outcomes in the US Appalachian area compared to nearby non-Apalachian regions. 3. Nancy Lennon, PT DPT MS Department of Orthopedics, Division of Therapeutic and Rehabilitation Services, Nemours Children's Health, Wilmington, Delaware, USA “Factors Associated With Short-Term Recovery Following Single-Event Multilevel Surgery for Children With Cerebral Palsy.” Nancy Lennon talks about her group's research findings of the effect of physical therapy on the outcome of single event multilevel surgery performed to improve motor function in children with cerebral palsy. 4. Natalie Fairbairn, MPH/MHM, OT Grace Centre for Newborn Intensive Care, The Children's Hospital, Westmead, Sydney, New South Wales, Australia. “Risk of Developmental Coordination Disorder in 8- and 9-Year-Olds Following Newborn Cardiac and Non–Cardiac Surgery” Natalie Fairbairn discusses the risks her group found of cardiac and non-cardiac surgery on newborn babies—in particular its effect on developmental co-ordination disorder. 5. James E Gehringer, PhD Research Assistant Professor Munroe-Meyer Institute, University of Nebraska Medical Center, Omaha, Nebraska “Hand-Arm Bimanual Intensive Training in Virtual Reality: A Feasibility Study” James Gehringer explains how his group integrated virtual reality with Hand-Arm Bimanual Intensive Training (HABIT) for treating unilateral cerebral palsy. The research appeared to overcome some of the frequently encountered barriers to progress. 6. Johannes J Noordstar, PhD MSc, Assistant Professor, Center for Child Development, Exercise & Physical Literacy, Wilhelmina Children's Hospital, University Medical Centre, Utrecht University, Netherlands. “Is Measuring Physical Literacy in School-Aged Children With Cystic Fibrosis or Congenital Heart Disease Needed?” Physical therapy researcher Johannes Noordstar talks about his group's research on whether “physical literacy” should be assessed in school-age children with cystic fibrosis or congenital heart disease. 7. Helen Carey, PT DHSc PCS College of Health Sciences, University of Indianapolis, Indiana USA “Early Developmental Trends in High-Risk Neonates Later Diagnosed With Autism Spectrum Disorder” Helen Carey talks about her findings (published in Pediatric Physical Therapy) from a study of high-risk neonates showing how autism spectrum disorder can be detected very early in life.

Before John Killian's toddler son was diagnosed with Duchenne muscular dystrophy (DMD), doctors told parents to simply take their children home and love them. The disease weakens the body's muscles and cognitive functions, which can lead to premature death. John's son is now college-bound, thanks to the help of medical advancements that target the symptoms of the disease. Geneticist Dr. Alison McVie-Wylie and the research team at Vertex hope to move past only treating the symptoms of DMD by addressing the disease at its root cause. Produced by Bloomberg Media Studios and Vertex Pharmaceuticals. Featured guests:John Killian is the proud father of Sam Killian, who lives with DMD.Mena Scavina is a Neurologist and Clinical Director at Nemours Children's Health and a Clinical Care Team Advisor at Parent Project Muscular Dystrophy.Jon Rey-Hastie is the Co-Founder of Pathfinders Neuromuscular AllianceDr. David Altshuler is the Executive Vice President, Global Research and Chief Scientific Officer at Vertex Pharmaceuticals. Alison McVie-Wylie is a Vice President leading the Duchenne muscular dystrophy research team at Vertex Pharmaceuticals.Read more about Vertex's approach to targeting Duchenne muscular dystrophy. 

The word of the season -  you're hearing it everywhere - is tripledemic. What is it? How might it affect you and your family, especially your children, and, perhaps most importantly, what can you do to keep yourself and your family safe and healthy?  On Nov. 29th, The Nemours Community Relations team put together a webinar featuring Nemours experts in pediatrics and infectious diseases to provide information on the current tripledemic landscape and answer parents' questions about it. It's information so important we're highlighting it on the podcast this week and featuring our experts' answers to parents' questions posed in the webinar next week.  The voices you hear are those of Dr. Kenneth Alexander, board certified by the American Board of Pediatrics in Infectious Diseases and Chief of the Division of Infectious Diseases at Nemours Children's Hospital in Orlando, and Dr. Maria Petrini. Dr. Petrini is a board-certified pediatrician at Nemours Children's Health, Delaware. She also serves as the medical director of the Delaware Children's Health Network.  Nemours pediatrician Dr. Laura Chilcutt serves as moderator. Dr. Chilcutt is a policy advisor with the external affairs team at Nemours Children's Hospital in Orlando.  Carol Vassar, producer

It's Thanksgiving week when families gather to celebrate that for which they are grateful. With the family together in one place, it's a rare opportunity for relatives to talk about and even record family history, including family health histories. That's one lesson that is being learned by teenagers across the nation whose teachers have chosen to avail themselves of a no-cost, evidence-based health education curriculum called "Navigating the Health Care System," developed here at Nemours. Today we are joined by the Nemours associates who created and have made available this curriculum and teachers from Delaware, Illinois, and Alabama to talk about how they have used or are using it in their classrooms.  Kate Blackburn and Denise Hughes from Nemours Children's Health, along with Anyana Starling, Program Manager, Health Literacy Program, Southeast Alabama Area Health Education Center; Christine DeGuzman, Health Education teacher, Brookside campus, Waukegan High School, Waukegan, Illinois and Katie Marianello, Delaware teacher and original curriculum pilot researcher.  Download the "Navigating the Health Care System" curriculum here.  Carol Vassar, producer

Throughout the history of Nemours Children's Health, research has been a crucial part of our mission. As a natural companion effort with clinical work, it has been central to serving patients and families in Delaware, Florida, and beyond.  Nemours' Executive Director of Research, Dr. Vicky Funanage, visits the podcast to provide an overview of research across the enterprise and a preview of Delaware Valley Research Week events happening from Oct. 17 through Oct. 21.  Agenda for 2022 Delaware Valley Research Week Attend virtually via Microsoft TEAMS on Mon., Oct. 17, from 8 a.m. - 1 .m.: Click here to join the meeting Meeting ID: 276 459 548 918 Passcode: oxEiqk Attend virtually via Microsoft TEAMS on Tues., Oct. 18, from 12 noon - 6 p.m.: Click here to join the meeting Meeting ID: 258 514 676 747 Passcode: qx2qVP Attend virtually via Microsoft TEAMS on Wed., Oct. 19, from 9 a.m. - 1 p.m.: Click here to join the meeting Meeting ID: 256 850 520 441 Passcode: E247qv Attend virtually via Microsoft TEAMS on Thurs., Oct. 20, from 9 a.m. - 2 p.m.: Click here to join the meeting Meeting ID: 243 803 565 109 Passcode: YhYQYM Attend virtually via Microsoft TEAMS on Fri., Oct. 21, from 12 noon - 4 p.m.: Click here to join the meeting Meeting ID: 243 803 565 109 Passcode: YhYQYM  

Dr. Suken Shah of Nemours Children's Health joins Nick Fletcher at the SRS Annual Meeting for a broad-ranging conversation. They discuss their approaches to wellness, including sleep habits, exercise, and meditation. They also touch on how to bounce back from complications, keeping your practice up-to-date, book recommendations, and much more. Produced by Nick Fletcher and Carter Clement. Music by Christian Bjoerklund.

Dr. Maryse Bouchard from The Hospital for Sick Children ("SickKids") in Toronto honors the show with her presence this month. The conversation focuses on her specialties of foot & ankle and limb deformity but also branches into other areas. Thanks to our sponsor, Nemours Children's Health. Your hosts are Craig Louer from Vanderbilt, Carter Clement from Children's Hospital of New Orleans, Josh Holt from Iowa, and Julia Sanders from Children's Hospital Colorado. Music by A.A. Aalto.   Main Event articles: Addar A, Bouchard M. Clinically Detected Leg Length Discrepancy in Patients With Idiopathic Clubfoot Deformity: Prevalence and Outcomes. J Pediatr Orthop. 2022 Aug 1;42(7):e772-e776. doi: 10.1097/BPO.0000000000002178. Epub 2022 May 10. PMID: 35543605. Trottier ÉR, Hatcher L, Feng J, Camp M, Bouchard M. Incidence of secondary interventions after early spica casting for diaphyseal femur fractures in young children. Can J Surg. 2022 Jul 5;65(4):E417-E424. doi: 10.1503/cjs.006521. PMID: 35790240; PMCID: PMC9337866. Lightning Round articles:   Sisman A, Avci O, Cepni SK, Cullu E. Is There a Chance to Treat Modified Gartland Type IIB Pediatric Supracondylar Humerus Fractures With Closed Reduction and Casting? J Pediatr Orthop. 2022 Sep 1;42(8):e821-e827. doi: 10.1097/BPO.0000000000002210. Epub 2022 Jul 14. PMID: 35834371. Mahan, S. T., Miller, P. E., May, C., Kasser, J. R., & Spencer, S. A. (2022). Bilateral Tarsal Coalitions: Are Postoperative Outcomes Different From Unilateral? Original Research. JPOSNA®, 4(3). Retrieved from https://jposna.org/index.php/jposna/article/view/428 Cummings JL, Hosseinzadeh P. Patient-Reported Pain and Function Outcomes in Children with Congenital Vertical Talus Treated With the Minimally Invasive Method. J Pediatr Orthop. 2022 Sep 2. doi: 10.1097/BPO.0000000000002259. Epub ahead of print. PMID: 36053022. Badin D, Raad M, Sponseller PD. Tibial Tuberosity Fracture: A Highly Selective Injury. J Pediatr Orthop. 2022 Aug 24. doi: 10.1097/BPO.0000000000002247. Epub ahead of print. PMID: 35998240. Paek S, Mo M, Hogue G. Treatment of paediatric Lisfranc injuries: A systematic review and introduction of a novel treatment algorithm. J Child Orthop. 2022 Jun;16(3):198-207. doi: 10.1177/18632521221092957. Epub 2022 May 10. PMID: 35800659; PMCID: PMC9254024.

Mike Sacopulos interviews Gary Josephson, MD, CPE, MBA, chief medical officer at Nemours Children's Health, in Jacksonville, Florida, about his new book, Ordinary to Extraordinary: Seven Principles for Life Success.  This book is a useful tool to improve one's life. Dr. Josephson provides wise counsel on the “7” principles that guide his life, and suggestions for all individuals on how to view life from ordinary to extraordinary. Dr. Josephson describes adversity, his physician leadership journey, and his work as a Certified Physician Executive (CPE). https://www.o2e4life.com/ Learn more about the American Association for Physician Leadership at www.physicianleaders.org  

Mike Sacopulos interviews Gary Josephson, MD, CPE, MBA, chief medical officer at Nemours Children's Health, in Jacksonville, Florida, about his new book, Ordinary to Extraordinary: Seven Principles for Life Success.  This book is a useful tool to improve one's life. Dr. Josephson provides wise counsel on the “7” principles that guide his life, and suggestions for all individuals on how to view life from ordinary to extraordinary. Dr. Josephson describes adversity, his physician leadership journey, and his work as a Certified Physician Executive (CPE). https://www.o2e4life.com/ Learn more about the American Association for Physician Leadership at www.physicianleaders.org  

It's Labor Day, and we're talking labor and delivery within the Advanced Delivery Program (ADP) at the Nemours Children's Hospital (NCH) in Delaware. It's a two-and-a-half-year-old program that started as a partnership between ChristianaCare and Nemours Children's Health aimed at having mom's deliver at NCH Delaware if their child had been diagnosed with a fetal anomaly requiring treatment immediately following birth. Nemours is taking on this program solo starting this month, and here to tell us about it are Nemours associates Dr. Margaret Chou and Dr. Joanna Costa.  Carol Vassar, producer

It's in the news! The top stories and headlines around the diabetes community this week include new progress in the quest for oral insulin to treat type 1, a new study says a common type 2 diabetes drug may help those with serious heart condition, a look at teen brains and T1D, NSAID and type 2 and more! Learn about the T1d Exchange: www.t1dexchange.org/stacey  Check out Stacey's book: The World's Worst Diabetes Mom! Join the Diabetes Connections Facebook Group! Sign up for our newsletter here ----- Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners! ----- Episode Transcription Below (or coming soon!) Please visit our Sponsors & Partners - they help make the show possible! *Click here to learn more about OMNIPOD* *Click here to learn more about AFREZZA* *Click here to learn more about DEXCOM* Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and these are the top diabetes stories and headlines of the past seven days. XX In the news is brought to you by T1D Exchange! T1D Exchange is a nonprofit organization dedicated to improving outcomes for the entire T1D population. https://t1dexchange.org/stacey/ XX Our top story.. very early on here, but some progress in oral insulin for type 1. A team at University of British Columbia has developed a different kind of tablet that isn't made for swallowing, but instead dissolves when placed between the gum and cheek. This method delivered all the insulin to the liver without wasting or decomposing any insulin along the way. That's a big change from earlier studies and methods. The oral tablets absorb after about half an hour and last for up to four hours.. long way to go, no human trials yet. The the lead researcher on this project has a father with type 1 . https://www.sciencedaily.com/releases/2022/08/220830093215.htm?fbclid=IwAR1AzjI5UJma9I6g4hST044FS0MbJnUA0EXCmKXyhcOiOKL-ckIQTO4h8dY XX The type 2 diabetes drug dapagliflozin might also be used to help people with heart failure. A new study at Brigham and Women's Hospital showed that dapagliflozin – sold under the brand name Farxiga - reduced the risk of a cardiovascular death, or worsening heart failure, regardless of ejection fraction. Ejection fraction is a term that basically refers to how much blood is pumped out by the left ventricle of the heart each time it contracts. That's important because this drug has already been shown to help people who have the reduced pumping. And that's a lot more people. Big study here, more than 12-thousand people with lots of ages and races, benefits consistent throughout. https://www.bostonglobe.com/2022/08/29/business/brigham-womens-researchers-say-diabetes-drug-helps-reduce-heart-failure/ XX I hesitate to bring this study up, but it's gotten a lot of attention this week. It shows tight control of blood sugar in teens with Type 1 diabetes may help reduce the disease's damaging effects on the brain. But this small study from Nemours Children's Health, Jacksonville and Stanford University School of Medicine didn't release any numbers, n other words, it's not clear what they mean by tight control or at what level they're referring to for brain issues. Their findings to indicate that automated hybrid closed loop systems work really well and that better glucose control can actually improve brain structure and function in teens with type 1. I've reached out to this group and we're working on getting more information in a future episode. https://neurosciencenews.com/blood-sugar-brain-diabetes-21328/ XX Very early on here.. but an Indiana startup says they have a potentially game changing type 1 drug in development. In T1D, the body's immune system causes destruction of beta cells, and as a result, they eventually stop producing insulin. These researchers say their models show thy can take what were thought to be dead beta cells, which are actually sleeping beta cells, and increase their insulin secretion and, basically, get them back to a functional state.” They're focusing on a calcium imbalance within the beta cell and designing molecules to correct that calcium imbalance, ultimately returning the pancreas to a healthy state. JDRF has given them a big grant for a two year project, hopefully getting them to clinical trials. https://www.insideindianabusiness.com/articles/startup-awarded-nearly-1m-to-advance-diabetes-drug XX People with type 2 diabetes might face a substantially increased risk of heart failure if they take ibuprofen or some other type of nonsteroidal anti-inflammatory drug (NSAID), accord to a new Danish study. Short-term NSAID use increased risk of hospitalization for heart failure by 43% in people with type 2 but no previous heart problems. This was a large but preliminary study presented at the European Society of Cardiology's annual meeting. NSAIDs increased the risk of heart failure even more in type 2 diabetics who were 80 or older (78%) or who had high blood sugar levels (68%), the results showed. Those who'd never used an NSAID before had the worst reaction, with their heart failure risk nearly tripling. Type 2 diabetics should consult with their doctor before taking any pain medicine, the doctors said. Other types of pain meds -- specifically acetaminophen (Tylenol) -- should be safe for them to use. https://www.usnews.com/news/health-news/articles/2022-08-24/certain-painkillers-raise-heart-failure-risk-in-people-with-type-2-diabetes XX Back to the news in a moment but first.. The T1D Exchange Registry is a research study conducted online over time, designed to foster innovation and improve the lives of people with T1D. The platform is open to both adults and children with T1D living in the U.S. Personal information remains confidential and participation is fully voluntary. Once enrolled, participants will complete annual surveys and have the opportunity to sign up for other studies on specific topics related to T1D. The registry aims to improve knowledge of T1D, accelerate the discovery and development of new treatments and technologies, and generate evidence to support policy or insurance changes that help the T1D community. By sharing opinions, experiences and data, patients can help advance meaningful T1D treatment, care and policy. The registry is now available on the T1D Exchange website and is simple to navigate, mobile and user-friendly. For more information or to register, go to www.t1dregistry.org/stacey XX We told you about The Human Trial, Watch this gripping new documentary about the brave men and women who volunteer to test a radical new treatment for type 1 diabetes. n 2011, Lisa Hepner and her husband Guy Mossman heard about a radical stem cell treatment for diabetes, a disease that shockingly kills more than five million people each year. Driven by a desire to cure Lisa of her own type 1 diabetes (T1D), the filmmakers were given unprecedented, real-time access to a clinical trial — only the sixth-ever embryonic stem cell trial in the world. What follows is an intimate journey with the patients and scientists who put themselves on the line to be first. Now, in partnership with Beyond Type 1 & JDRF , they're offering the film for free. You are urged to make a donation to JDRF when you click over, there is an option to select zero, https://watch.showandtell.film/watch/the-human-trial-beyond-type-1 XX Next week we've got a great episode all about Omnipod 5 in the real world. I spoke to a panel of moms and a young adult using the system. And we've got Insulet's Director of Medical affairs addressing the questions that come up. This past episode is with my son Benny, talking about what it was like to spend 8 weeks away at non diabetes camp without any remote monitoring from us. Listen wherever you get your podcasts That's In the News for this week.. if you like it, please share it! Thanks for joining me! See you back here soon.

Ryan Gorman hosts an iHeartRadio nationwide special featuring Dr. Adriana Cadilla, a pediatric infectious disease specialist at Nemours Children's Health in Orlando. Dr. Cadilla discusses COVID-19 and the return of kids back to school. Plus, the Executive Director of the 988 Suicide and Crisis Lifeline, Dr. John Draper, checks in to recap the launch of 988 and explain how the new national suicide prevention line will help those dealing with a mental health crisis.

Dr. Erica Sood is a pediatric psychologist at Nemours Children's Health and an Associate Professor of Pediatrics at Sidney Kimmel Medical College of Thomas Jefferson University. She directs the Nemours Cardiac Learning and Early Development (LEAD) Program and trains psychology fellows in the specialty area of cardiac neurodevelopment. Her research focuses on partnering with stakeholders to develop and test family-based psychosocial interventions to promote family wellbeing and child developmental outcomes.Find out more about Erica and this episode at: www.the-incubator.org________________________________________________________________________________________As always, feel free to send us questions, comments or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through instagram or twitter, @nicupodcast. Or contact Ben and Daphna directly via their twitter profiles: @drnicu and @doctordaphnamd. enjoy!This podcast is proudly sponsored by Chiesi.

Mr. Laws is an accomplished corporate executive leader with over 25 years of extensive experience working within the top Fortune 20 companies. Prior to joining Nemours Children's Health, Mr. Laws held several C-Suite roles to include Global Sr. Diversity, Equity and Inclusion Manager role with Amazon. Executive Leadership roles with Starbucks Coffee Company, two Japanese pharmaceutical sales/marketing firms and Mobil Oil Corporation. Mr. Laws hold a Master's degree in Business Management, Bachelor's degree in Business Marketing and Executive Leadership Certificates from Harvard University. Member of the Orlando Regional Realtor Association.

Ryan Gorman hosts an iHeartRadio nationwide special featuring Dr. Kenneth Alexander, Chief of Infectious Diseases at Nemours Children's Health in Florida. Dr. Alexander discusses the latest information regarding children and COVID-19. Kelly Navies, Museum Specialist of Oral History at the Smithsonian National Museum of African American History and Culture, also joins the show to discuss the history of Juneteenth.

Part I of the POSNA 2022 Annual Meeting content.  In this episode, we interview moderators and course chairs from the first few days of the POSNA 2022 Annual Meeting in Vancouver, BC, Canada--INCLUDING the Pre-Course, Wednesday Scientific Sessions, POPS (Pediatric Orthopedic Practitioners Society) Conference, and the ever-popular Sub-Specialty Day. Your hosts are Dr. Craig Louer from Vanderbilt , Dr. Carter Clement from Children's Hospital of New Orleans, and Dr. Julia Sanders of Children's Hospital Colorado.  Music by A. A. Aalto.  Support for this episode provided by Nemours Children's Health network.

 Alfred Atanda Jr., MD is a pediatric, sports medicine orthopedic surgeon at Nemours Children's Health in Wilmington, Delaware where he serves as the Chief of the Center for Sports Medicine and the Director of Clinician Well-Being. A graduate of the University of Pennsylvania School of Medicine, he completed residency at the University of Chicago Medical Center. Dr. Atanda also completed fellowships in pediatric orthopedic surgery, at Alfred I DuPont Hospital for Children, and in sports medicine surgery, at the Rothman Institute at Thomas Jefferson University. His future goals and aspirations are to re-imagine how healthcare is delivered by leveraging digital health and telemedicine technology to appropriately triage, navigate, evaluate, and treat orthopedic patients. He is the chief editor of the world's first textbook solely dedicated to telemedicine in orthopedic surgery and sports medicine, and he has also launched a telemedicine concierge service for the parents of youth athletes: “ SportsLinkMD”. He is a physician expert for numerous telemedicine companies providing strategic advice and e-consultations to urgent care, emergency department, and primary care physicians, as well as a second opinions directly to patients. In his non-surgical role, he has been working to optimize the physician experience, bringing awareness to the many ramifications of physician burnout, lack of well-being, and physician suicide. He is a speaker at wellness spas and resorts and is developing a physician well-being podcast for the orthopedic surgery educational platform “OrthoBullets”.  Laurel Mintz, founder and CEO of award-winning marketing agency Elevate My Brand, explores some of the most exciting new and growing brands in Los Angeles and the US at large. Each week, the Elevate Your Brand podcast features an entrepreneurial special guest to discuss the past, present and future of their brand.

When Dr. Bachrach joined Nemours in 1987, he became a witness to - and a driver of - the changes that would occur here that helped set the stage for "Well Beyond Medicine," including the transition from an orthopedic-only institution to a full-service pediatric hospital, the establishment of a world-renowned cerebral palsy center, the building of a new hospital in Orlando, and the evolution of Nemours Children's Health into a full-fledged pediatric healthcare system.    In this episode, Dr. Bachrach shares highlights of his distinguished Nemours career, memories of patients who inspired him, colleagues who have become his friends, and his perspective on change, retirement, and the Nemours culture that brought him here.    Carol Vassar, producer

Dr. Larry Moss joins JMN to discuss Nemours Children's Health partnerships with WOKV, Child Cancer Fund, and The Players.

PedsAcademy is a unique, research-backed partnership between Nemours Children's Health and the University of Central Florida. It provides education to Nemours patients with chronic health conditions and complex medical needs. It also offers a formal internship program for teachers in training - the only such program of its kind in the nation. It gives future teachers deep insight and understanding into the educational and social-emotional needs of children coping with chronic illness -- training and experience that they carry with them to their classrooms and careers. Carol Vassar, producer RESOURCES: Visit PedsAcademy at Nemours Visit PedsAcademy at UCF An Exploration of the PedsAcademy Internship's Influence on Aspiring Educators' Preparation to Teach Children with Chronic Illnesses.

In 2012, Anabelle Burgos joined Nemours Children's Health in Florida as part of the BrightStart! pre-school literacy program. It was a position she loved with an organization whose mission aligned with her values. Yet an unplanned break in her career meant leaving Nemours in 2016. This hiatus gave Annabelle time to reflect on her early career: where it had been, and where it was going. What she liked, and what she wanted to change. Turns out, she loved working a Nemours,  so she set her sights on returning - this time, as a clinical research nurse coordinator! Carol Vassar, producer

This episode features R. Lawrence Moss, M.D., President and CEO at Nemours Children's Health System. Here, he discusses how his strategies are evolving, what his top priorities are, and more

Bright Spot #20 - Interview with Kara Odom Walker MD of Nemours Children's Health

This episode features R. Lawrence Moss, M.D., President and CEO at Nemours Children's Health System. Here, he discusses how his strategies are evolving, what his top priorities are, and more.

I speak with Dr. Jay Greenspan, CEO of Nemours Children's Health Systems Delaware Valley and Greater Delaware Valley Mission Initiative Chair for the March of Dimeshttps://www.marchofdimes.org/

We continue with the second in a two month long series dedicated to raising awareness about Premature births and maternal health with the March of Dimes. I speak with Dr. Jay Greenspan, CEO of Nemours Children's Health Systems Delaware Valley and Greater Delaware Valley Mission Initiative Chair for the March of Dimeshttps://www.marchofdimes.org/

We begin with the first in a two month long series dedicated to raising awareness about Premature births and maternal health with the March of Dimes. I speak with Dr. Jay Greenspan, CEO of Nemours Children's Health Systems Delaware Valley and Greater Delaware Valley Mission Initiative Chair for the March of Dimeshttps://www.marchofdimes.org/